Cara Therapeutics: Navigating Setbacks and Riding the Waves in Biopharmaceuticals
The biopharmaceutical industry has seen a flurry of activity lately, with several companies vying for a spot in the spotlight. ...
Tag: CARA
Cara Therapeutics Receives Buy Rating from HC Wainwright Co Analyst with Lowered Price Target
As of May 16, 2023, Cara Therapeutics (NASDAQ:CARA) has received a Buy rating from HC Wainwright & Co. analyst Oren ...
Cara Therapeutics Reports Q1 Earnings and Clinical Program Progress Despite Setbacks
On May 15, 2023, Cara Therapeutics, a biopharmaceutical company in the commercial stage, released its Q1 earnings report. The report ...
Cara Therapeutics Exceeds Analyst Expectations in Q1 Earnings Report
On May 15, 2023, Cara Therapeutics (NASDAQ:CARA) released its Q1 earnings report, revealing a loss of $26.7 million or $(0.49) ...
Los Angeles Capital Management LLC reduces position in biopharmaceutical company Cara Therapeutics Inc.
Los Angeles Capital Management LLC, a top-tier investment firm, has reduced its position in the NASDAQ-listed biopharmaceutical company Cara Therapeutics ...
Cara Therapeutics Inc. Receives Moderate Buy Recommendation from Analysts and Gains Institutional Investor Interest
On April 11, 2023, Bloomberg Ratings reported that the shares of Cara Therapeutics, Inc. (NASDAQ:CARA) had been assigned an average ...
Cara Therapeutics Faces Drop in Short Interest as CEO Completes Share Sale
Cara Therapeutics, Inc. (NASDAQ:CARA) recently faced a significant drop in short interest during the month of March, according to reports. ...
“Cannabis Stock Performance on March 17, 2023”
On March 17, 2023, the cannabis stock market had both gainers and losers. Let's look at the companies that had ...